Upfront metastasis ‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.

Source: Medical Oncology - Category: Cancer & Oncology Source Type: research